Turkey: OTC pharmaceuticals segment revenue 2027

In 2022, analgesics recorded the highest revenue with over 101 million U.S. dollars among all segments of the over-the-counter (OTC) pharmaceuticals market in Turkey. Ranking second, the vitamins and minerals segment generated a revenue of 74.3 million U.S. dollars. All segments of the over-the-counter (OTC) pharmaceuticals market in Turkey are forecast to increase their revenue over the upcoming years except for the hand sanitizer segment.

Revenue of the over-the-counter (OTC) pharmaceuticals market in Turkey from 2018 to 2027, by segment (in million U.S. dollars)

Characteristic	Analgesics	Vitamins & Minerals	Cold & Cough Remedies	Digestives & Intestinal Remedies	Skin Treatment	Hand Sanitizer
-	-	-	-	-	-	-
-	-	-	-	-	-	-
-	-	-	-	-	-	-
-	-	-	-	-	-	-
-	-	-	-	-	-	-
-	-	-	-	-	-	-
-	-	-	-	-	-	-
-	-	-	-	-	-	-
-	-	-	-	-	-	-
-	-	-	-	-	-	-

Download

Source

Show detailed source information?

Already a member?

Sources

Use Ask Statista Research Service

More information

Supplementary notes

Data provided by Statista Market Insights are estimates.

The Over-the-Counter Pharmaceuticals market comprises over-the-counter medicine that can be purchased without a medical prescription. The market is subdivided into Analgesics, Cold and Cough Medication, Digestives and Intestinal Remedies, Skin Treatment products and Vitamins and Minerals. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Citation formats